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Table. Clinical outcomes in all study patients
Medication Revascularization
Unadjusted
HR (95% CI)
p
Value
3Adjusted HR(95%
CI)
p
Value
Total population
(n¼738)
n¼236 n¼502
All-cause death 44 (18.6) 39 (7.8) 0.39 (0.26-0.61) <0.01 0.44 (0.27-0.71) <0.01
Cardiac death 23 (9.7) 17 (3.4) 0.33 (0.18-0.61) <0.01 0.29 (0.15-0.58) <0.01
MI 2 (0.8) 4 (0.8) 0.91 (0.17-4.98) 0.92 1.04 (0.16-6.80) 0.97
1Repeat
revascularization
37 (15.7) 34 (6.8) 0.38 (0.24-0.61) <0.01 0.38 (0.23-0.63) <0.01
2MACE 59 (25.0) 51 (10.2) 0.36 (0.25-0.52) <0.01 0.32 (0.21-0.49) <0.01
Data are presented as n (%).
1Repeat revascularization included target vessel revascularization-PCI, non-target vessel
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Transradial CTO PCI can be performed with similar success and
complication rates with transfemoral CTO PCI, but is associated with longer proce-
dural and ﬂuoroscopy times.
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Background: Patients with coronary artery disease with a chronic total occlusion (CTO)
are associated with worse clinical outcome compared to patients without a CTO.
Percutaneous coronary intervention (PCI) of CTOs may have a beneﬁcial effect on
survival. In literature mainly small, observational and predominantly single center studies
exist about successful PCI and the impact on reducing long-term mortality for CTO.
Methods: This meta-analysis compared the long-term mortality of successful versus
failed PCI for CTO. Relevant studies were examined and analyzed independently by
two investigators. To prevent distortion of the results by the inclusion of (sub-)acute
100% occlusions, a subgroup analysis was performed on only those studies which
included patients with a CTO of at least 3 months.
Results: We identiﬁed 27 studies eligible for inclusion in this meta-analysis, including
11,085 CTO patients with successful and 4,347 CTO patients with unsuccessful revas-
cularization (mean follow-up duration 1 to 10 years). We did not ﬁnd any randomized
controlled trials between CTO PCI versus medical treatment only. Successful CTO PCI
was associated with reduced mortality in comparison to failed CTO PCI (odds ratio
(OR): 0.52, 95%CI: 0.43-0.62,p-value¼ 0.01). For the subgroup analyses the results
remained qualitatively similar (OR: 0.47, 95%CI: 0.35-0.64, p-value < 0.01) (ﬁgure 1).
Conclusions: This meta-analysis conﬁrmed previous ﬁndings of a reduced mortality
after successful versus failed CTO PCI. Randomized controlled trials are needed to
conﬁrm the value of PCI in patients with a CTO in reducing the mortality.revascularization-PCI and coronary artery bypass grafting (CABG).
2Major adverse cardiac events (MACE) included cardiac death, MI, and repeat revasculariza-
tion with PCI or CABG.
3Adjusted covariates include age, ACS, CTO of LAD, multiple CTOs, previous PCI and Proximal
to mid CTO
ACS ¼ acute coronary syndrome; CI ¼ conﬁdence interval; CTO ¼ coronary chronic total oc-
clusion; HR ¼ hazard ratio; LAD ¼ left anterior descending artery; MI ¼ myocardial infarction;
PCI ¼ percutaneous coronary interventionTCT-197
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Background: Little is known about the clinical outcomes and optimal treatment
strategies of chronic total occlusion (CTO) with well-developed collateral circulation.B58 JACC Vol 64/11/Suppl BMethods: We screened 2,024 consecutive patients with at least one CTO detected on
coronary angiogram. Of these, we analyzed data from 738 patients with Rentrop 3
grade collateral circulation who were treated with medical therapy alone (n¼236),
coronary artery bypass grafting (n¼170) or percutaneous coronary intervention (PCI)
(n¼332; 80.1% successful). Patients who underwent revascularization and medical
therapy (revascularization group, n ¼502) were compared to those who underwent
medical therapy alone (medication group, n¼236) in terms of cardiac death and major
adverse cardiac events (MACE), deﬁned as the composite of cardiac death, myocar-
dial infarction, or repeat revascularization.
Results: During a median follow-up duration of 42 months, multivariate analysis
revealed a signiﬁcantly lower incidence of cardiac death (hazard ratio [HR] 0.29; 95%
conﬁdence interval [CI] 0.15 to 0.58; p< 0.01) and MACE (HR 0.32; 95% CI 0.21 to
0.49; p< 0.01) in the revascularization group compared to the medication group. After
propensity score matching, the incidence of cardiac death (HR 0.27; 95% CI 0.09 to
0.80; p¼0.02) and MACE (HR 0.44; 95% CI 0.23 to 0.82; p¼0.01) were still
signiﬁcantly lower in the revascularization group than in the medication group.Conclusions: In patients with coronary CTO and well-developed collateral circula-
tion, aggressive revascularization may reduce the risk of cardiac mortality and MACE.
These ﬁndings need to be conﬁrmed in randomized controlled trials.
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Background: The aim of this study was to describe the ﬁve-year European experience
of retrograde percutaneous coronary interventions (PCI) revascularization for complex
chronic total occlusions (CTOs) of coronary arteries.
Methods: Demographic data, procedural outcomes and in-hospital clinical events
were collected on 1582 consecutive lesions of 1395 patients enrolled between January
2008 and December 2012 having retrograde CTO PCI at 44 European medical centers
by 45 experienced interventionalist operators. A retrograde J-CTO score was used to
better describe success according to lesion difﬁculty. Data about clinical follow-up
were collected.
Results: Patients mean age was 62.0  10.4 years. During the procedure the retro-
grade approach was used as ﬁrst line strategy in 76.2% of cases, while immediately
after antegrade failed approach in 23.8% of cases. Procedural success was achieved
in 75.3% of cases. A major complication occurred in 16 patients (1.0%). In multi-
variable analysis, age of the patient (per 10-year increase) (OR:1.19, 95%CI:1.03-
1.34; p¼0.02), lower operator volume (OR:3.00, 95%CI:2.41-4.21; p< 0.001) and
increased retrograde J-CTO score (OR:0.42, 95%CI:0.24-0.74; p< 0.001) were
recognized as independent predictors of procedural failure. The mean follow-up
period was 24.7  15.0 months. Major adverse cardiac and cerebral events
(MACCE) occurred in 13.6% of cases (cardiac death 1.9%, myocardial infarction
3.2%, stroke 0.6% and target vessel revascularization 13%). By multivariate Cox
regression, the independent predictors of MACCE were: male gender (HR:0.47, 95%
CI:0.30-0.74; p¼0.01); prior myocardial infarction (HR:1.45, 95%CI:1.01-2.09;
p¼0.04); number of previous attempts (HR:1.63, 95%CI:1.36-1.95; p< 0.001); CTO
length (HR:1.01, 95%CI:1.00-1.02; p¼0.004); and total stent length (HR:0.98, 95%
CI:0.97-0.98;p< 0.001).
Conclusions: In Europe among selected centers dedicated to CTO revascularization,
retrograde approach was performed over a 5-year period in 16.5% of these patients.j September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
